Treatment of Mild Headache in Disabled Migraine Sufferers: Results of the Spectrum Study
about
Sumatriptan (oral route of administration) for acute migraine attacks in adultsOral sumatriptan for acute migraineOral sumatriptan for acute migraineAcetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trialAdvances in pharmacological treatment of migraineAcetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial--a commentAcute migraine treatment: patterns of use and satisfaction in a clinical populationThe premonitory symptoms (prodrome): a tertiary care study of 893 migraineursPatients with migraine are right about their perception of temperature as a trigger: time series analysis of headache diary data.Clinical benefits of early triptan therapy for migraine.New appendix criteria open for a broader concept of chronic migraine.Primary headaches: a convergence hypothesis.New paradigms in the recognition and acute treatment of migraine.Communicating the right therapy for the right patient at the right time: acute therapy.Triptans for migraine management in adolescents.A review of the clinical efficacy and tolerability of almotriptan in acute migraine.Double-blind clinical trials of oral triptans vs other classes of acute migraine medication - a review.Triptans and CNS side-effects: pharmacokinetic and metabolic mechanisms.Migraine headache misconceptions: barriers to effective care.Eletriptan in migraine.Oral almotriptan: practical uses in the acute treatment of migraine.Early treatment of migraine attacks with triptans: a strategy to enhance outcomes and patient satisfaction?Sumatriptan: update and review.The convergence hypothesis.Early treatment in migraine: how strong is the current evidence?Randomized, double-blind, crossover study comparing DFN-11 injection (3 mg subcutaneous sumatriptan) with 6 mg subcutaneous sumatriptan for the treatment of rapidly-escalating attacks of episodic migraine.Early treatment of acute migraine: new evidence of benefits.Influence of trigger factors on the efficacy of almotriptan as early intervention for the treatment of acute migraine in a primary care setting: the START study.Almotriptan: a review of 10 years' clinical experience.The biological basis of headache.Controversy over the classification of medication-overuse headache.Pharmacological synergy: the next frontier on therapeutic advancement for migraine.Symptomatic Overlap and Therapeutic Opportunities in Primary Headache.The pharmacokinetics and clinical efficacy of AVP-825: a potential advancement for acute treatment of migraine.Aspirin is first-line treatment for migraine and episodic tension-type headache regardless of headache intensity.Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).Subcutaneous sumatriptan provides symptomatic relief at any pain intensity or time during the migraine attack.Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.Advances in drug development for acute migraine.Cost-effectiveness of antiepileptic drugs in migraine prophylaxis.
P2860
Q24203707-F6180005-C3A3-4ADF-9B42-57176EBDA4FCQ24203742-571181BD-3E8F-44E0-90C7-550514502002Q24248078-E68B5677-F806-4CB5-AC5F-22B44193AAB5Q28188328-7D43218A-97B2-4618-B511-659B8B7BC74CQ28192002-7F320DCF-CC3F-49A2-81AA-D6BDDFC9148EQ28195314-05692438-3079-4293-AC53-2D143CB3BCDBQ28196819-8BD5EC09-24BE-4292-81F1-927450CC4661Q28284647-C91AB00F-70CF-436B-8E0A-ECE982854A02Q30960235-BBE67836-953E-4688-ADAC-30D63D571885Q34375885-3724CAC7-90EB-4461-AFBC-60538E30151AQ34523930-740D83FF-0D20-4A27-BDFD-3824C017AAE1Q34570686-0C18F2FA-9C5E-4EAE-A567-AD5DDD5829D7Q34634345-8659A03C-F0F2-415E-BAD6-D72AEF42716DQ34760003-DC29DF75-5904-4E35-9F16-FF6D97DFC897Q35025918-91D14680-78C7-460A-94C9-482F7ADDF594Q35164715-83BEC49A-83BC-4EA3-92EE-36A7FA6DD3C4Q35750750-BA6E3E14-0ECD-46BD-9F09-B4833D2B297FQ35779019-04D54EA0-7D36-4CD8-84C4-7446E44D6B9BQ35783724-0E366DBF-B45A-47A3-AF41-E3698850F1C2Q36106757-1B58611B-2064-4255-8771-A7843CDE451FQ36106933-DB777813-52B9-4776-BC90-93539AB24E69Q36532178-8289CA6A-461A-4E05-9029-BACFEC246E74Q36543148-BE959558-585B-4117-A51A-E7B046A59D60Q36787458-853F6A88-A24B-4AE5-8E8B-EB0190F58384Q37247872-4C4B6DDE-95CA-49AC-B360-2D8B60C278ECQ37629793-0312EDDB-C601-4A84-9E24-AF9D54C6BAFBQ37657619-6A4A5D6D-02D5-420C-AD06-705D1734320EQ37785552-B35D8C49-5931-4C29-A60F-B411284F0628Q37800072-4F1D7646-FA12-470A-92DD-472C967FA634Q37849764-2BA5BD7A-648D-40A6-B50D-4FDA20411008Q37954120-FBF4D122-94EA-4457-AE2D-11FB26C6A18CQ37973436-375179AA-67DD-4B28-BE52-2300E96344A4Q38238909-D2A5E7A3-0BDE-4651-8F2D-6949FFAF838FQ38563244-0A374B06-731A-44C8-AD0A-89FEA6AFE56BQ39260096-E2B18C0A-0F1A-4620-9499-3014DAD0B03FQ39339602-088DB30D-8830-40F0-975C-F41DC606315DQ39356297-23E19717-B4FF-4F28-9918-A68E51DD69A5Q39356656-845EE739-4382-468F-B238-8ACA555A741FQ39527265-C4D10522-4432-4DBF-BDE8-441046D4DE8AQ40619250-B1E52D1E-9EC0-4924-903C-83EAFCA58BBD
P2860
Treatment of Mild Headache in Disabled Migraine Sufferers: Results of the Spectrum Study
description
scientific article published on 01 November 2000
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2000
@uk
name
Treatment of Mild Headache in Disabled Migraine Sufferers: Results of the Spectrum Study
@en
Treatment of Mild Headache in Disabled Migraine Sufferers: Results of the Spectrum Study
@nl
type
label
Treatment of Mild Headache in Disabled Migraine Sufferers: Results of the Spectrum Study
@en
Treatment of Mild Headache in Disabled Migraine Sufferers: Results of the Spectrum Study
@nl
prefLabel
Treatment of Mild Headache in Disabled Migraine Sufferers: Results of the Spectrum Study
@en
Treatment of Mild Headache in Disabled Migraine Sufferers: Results of the Spectrum Study
@nl
P2093
P2860
P1433
P1476
Treatment of mild headache in disabled migraine sufferers: results of the Spectrum Study
@en
P2093
D Gutterman
W F Stewart
P2860
P304
P356
10.1046/J.1526-4610.2000.00144.X
P577
2000-11-01T00:00:00Z